1-4 of 4
Dana Buckman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity

Gang Li, Lianglin Zhang, Enhong Chen, Jianying Wang, Xin Jiang, Jeffrey H. Chen, Grant Wickman, Karin Amundson, Simon Bergqvist, James Zobel, Dana Buckman, Sangita M. Baxi, Steven L. Bender, Gerald F. Casperson, Dana D. Hu-Lowe
Journal: Cancer Research
Cancer Res (2010) 70 (24): 10243–10254.
https://doi.org/10.1158/0008-5472.CAN-10-1996
Published: 14 December 2010
View article titled, Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity
Open the PDF for Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity in another window
Includes: Supplementary data
Journal Articles

Abstract 5218: γ-secretase inhibitor PF-03084014 impairs Notch signaling and induces antiangiogenic and antitumor effects in breast cancer models

Cathy Zhang, Qin Zhang, Cory Painter, Zhengming Yan, Wendy Li, Dana Buckman, Xianxian Zheng, Kyle Kuszpit, Anthony Wong, Timothy Affolter, Patrick B. Lappin, Nathan V. Lee, Ping Wei, Ming Qiu, Sophia Randolph, Tod Smeal, James G. Christensen
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5218.
https://doi.org/10.1158/1538-7445.AM10-5218
Published: 15 April 2010
View article titled, Abstract 5218: γ-secretase inhibitor PF-03084014 impairs Notch signaling and induces antiangiogenic and antitumor effects in breast cancer models
Journal Articles

Abstract 1758: Preclinical assessment of using [18F]FLT-PET imaging as a surrogate proof-of-mechanism biomarker for early drug development candidates

Cathy Zhang, Zhengming Yan, Wendy Li, Kyle Kuszpit, Cory Painter, Qin Zhang, Kenneth Zasadny, Dana Buckman, Patrick Lappin, Anthony Wong, Maruja Lira, Sophia Randolph, Timothy McCarthy, James Christensen
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1758.
https://doi.org/10.1158/1538-7445.AM10-1758
Published: 15 April 2010
View article titled, Abstract 1758: Preclinical assessment of using [<sup>18</sup>F]FLT-PET imaging as a surrogate proof-of-mechanism biomarker for early drug development candidates
Journal Articles

CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10+ Tumors

Chin Pan, Pina M. Cardarelli, Matthew H. Nieder, Lesley B. Pickford, Sanjeev Gangwar, David J. King, Geoffrey T. Yarranton, Dana Buckman, William Roscoe, Fengmin Zhou, Adam Salles, Tseng-Hui Chen, Killian Horgan, Yi-Hong Wang, Thi Nguyen, Christopher R. Bebbington
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5526–5531.
Published: 18 September 2003
View article titled, CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10<sup>+</sup> Tumors
Open the PDF for CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10<sup>+</sup> Tumors in another window